Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors

Bioorg Med Chem Lett. 2009 Jul 1;19(13):3615-8. doi: 10.1016/j.bmcl.2009.04.132. Epub 2009 May 3.

Abstract

A novel compound inhibiting HIV-1 integrase has been identified by means of virtual screening techniques. A small family of structurally related molecules has been synthesized and biologically evaluated with some of the compounds possessing micromolar activity both in enzymatic and cellular assays.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / chemical synthesis
  • Anti-HIV Agents / chemistry*
  • Anti-HIV Agents / pharmacology
  • Cell Line
  • HIV Integrase / chemistry*
  • HIV Integrase / metabolism
  • HIV Integrase Inhibitors / chemical synthesis
  • HIV Integrase Inhibitors / chemistry*
  • HIV Integrase Inhibitors / pharmacology
  • HIV-1 / drug effects*
  • Humans
  • Rhodanine / chemical synthesis
  • Rhodanine / chemistry*
  • Structure-Activity Relationship
  • Thiobarbiturates / chemical synthesis
  • Thiobarbiturates / chemistry*
  • Thiohydantoins / chemical synthesis
  • Thiohydantoins / chemistry*

Substances

  • Anti-HIV Agents
  • HIV Integrase Inhibitors
  • Thiobarbiturates
  • Thiohydantoins
  • Rhodanine
  • HIV Integrase
  • thiobarbituric acid
  • p31 integrase protein, Human immunodeficiency virus 1